Last reviewed · How we verify
NCT04911556: TEOPOGP
the Effect of Probiotics on Aging Population
NA trial testing Bifidobacterium longum in Debility in 120 participants. Status unknown.
30 June 2022
Quick facts
| Lead sponsor | Wuxi People's Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 June 2021 |
| Primary completion | 30 June 2022 |
| Estimated completion | 31 December 2022 |
Drugs / interventions tested
- Bifidobacterium longum
- A placebo made of starch
Conditions studied
- Debility — all drugs for Debility →
Sponsor
Wuxi People's Hospital
Who can join
65 and older, any sex, with Debility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study intends to recruit aging population (over 65 years old). The investigators use 16 SrDNA sequencing technology, genome sequencing technology, metabonomics, random forest forecast model, analysing and selecting specific age-related intestinal flora. The investigators select probiotics slowing down senility. Then the investigators use the probiotics to intervene in the aging population. Finally the investigators observe whether the probiotics can delay aging.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Looking at frailty and intrinsic capacity through a geroscience lens: the ICFSR & Geroscience Task Force.
de Souto Barreto P, Rolland Y, Ferrucci L, Arai H, et al · · 2023 · cited 21× · PMID 37985720 · DOI 10.1038/s43587-023-00531-w
Verify or expand the search:
- PubMed search for NCT04911556
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bifidobacterium longum
Trials testing the same drug.
- NCT07420231 — Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort · NA · not yet recruiting
- NCT06639516 — Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Co · NA · not yet recruiting
- NCT05054309 — A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects W · NA · completed
- NCT04042181 — The Effects of Supplementation of a Probiotic, B. Longum, on BMI and Anthropometric Outcomes in Overweight/Obese Adults. · NA · unknown
- NCT03056846 — Probiotics on Stress-associated Gastrointestinal Function in University Students · NA · completed
Other recruiting trials for Debility
Currently open trials in the same condition.
- NCT06586970 — Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients · NA · recruiting
Other Wuxi People's Hospital trials
Trials by the same sponsor.
- NCT06430502 — Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced · NA · recruiting
- NCT06240767 — Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils · Phase 1 · unknown
- NCT06404528 — Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours · NA · recruiting
- NCT06430515 — The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors · NA · recruiting
- NCT05747339 — A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced So · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04911556 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wuxi People's Hospital
- Last refreshed: 3 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04911556.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing